PIK3R5 Products

Antibodies
PIK3R5 Antibody (601214)
PIK3R5 Antibody (601214)
MAB6388
Species: Hu
Applications: WB
Host: Mouse Monoclonal
Formulation Catalog # Availability Price  
Lysates
PIK3R5 Overexpression Lysate
PIK3R5 Overexpression Lysate
NBP2-09666
Species: Hu
Applications: WB
PIK3R5 Overexpression Lysate
PIK3R5 Overexpression Lysate
NBL1-14424
Species: Hu
Applications: WB
Proteins
PIK3R5 Recombinant Protein An ...
PIK3R5 Recombinant Protein Antigen
NBP2-49037PEP
Species: Hu
Applications: AC
PIK3R5 Recombinant Protein An ...
PIK3R5 Recombinant Protein Antigen
NBP2-57055PEP
Species: Hu
Applications: AC
PIK3R5 Recombinant Protein An ...
PIK3R5 Recombinant Protein Antigen
NBP2-58521PEP
Species: Hu
Applications: AC

Description

Phosphatidylinositol 3-kinase (PI 3-kinase) is composed of 85 kDa (p85) and 110 kDa (p110) subunits. p85 lacks PI 3-kinase activity and acts as an adapter, coupling p110 to activated protein tyrosine kinase. Two forms of p85 have been described (p85alpha and p85beta), each possessing one SH3 and two SH2 domains. Various p110 isoforms have been identified. p110alpha and p110beta interact with p85alpha, and p110alpha has also been shown to interact with p85beta in vitro. p110delta expression is restricted to white blood cells. It has been shown to bind p85alpha and beta, but it apparently does not phosphorylate these subunits. p110delta seems to have the capacity to autophosphorylate. p110gamma does not interact with the p85 subunits. It has been shown to be activated by alpha and betagamma heterotrimeric G proteins.

Bioinformatics

Entrez Human
Mouse
Uniprot Human
Human
Human
Human
Human
Product By Gene ID 23533
Alternate Names
  • F730038I15Rik
  • FOAP-2
  • p101
  • P101-PI3K
  • p101-PI3K
  • Phosphatidylinositol-4,5-bisphosphate 3-kinase regulatory subunit
  • phosphoinositide-3-kinase, regulatory subunit 5
  • phosphoinositide-3-kinase, regulatory subunit, polypeptide p101
  • PI3-kinase p101 subunit
  • PI3-kinase regulatory subunit 5
  • PtdIns-3-kinase regulatory subunit
  • regulatory subunit 5, p101